Bridger Management, LLC / ACAD
Bridger Management, LLC’s Acadia Pharmaceuticals Inc Position
Does Bridger Management, LLC own Acadia Pharmaceuticals Inc (ACAD)? Not currently — the last reported position was 117.3K shares worth $4M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q4 2023
Shares
117.3K
% of Portfolio
+1.42%
Quarters Held
1
position exited
Position History ACAD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2023 | 117.3K | $4M | +1.42% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridger Management, LLC’s full portfolio or all institutional holders of ACAD.